Brief

The inspection report highlights significant non-conformities and shortcomings at CENEXI's manufacturing facility. Noted issues include degraded facilities, inadequate maintenance, deficient cleaning operations, and unsatisfactory management of aseptic processes, documentation, and personnel training. The ANSM orders Cenexi to take corrective measures within specified deadlines to address these issues, including improving facility conditions, implementing robust maintenance management, and enhancing aseptic process simulation, product inspection, and microbiological control.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies